Skip to main content
Fig. 2 | BMC Complementary Medicine and Therapies

Fig. 2

From: Huang Lian Jie Du Decoction enhances the anti-tumor efficacy of immune checkpoint inhibitors by activating TLR7/8 signalling in melanoma

Fig. 2

Effects of HLJD for the treatment of B16F10 growth in vivo. (A) Schematic illustration of the experiment design. (B) Tumor growth curves on B16F10-tumor-bearing mice with different treatments as indicated. (C) Survival curves of mice in each group. (n = 6 mice/group). Differences in tumor volume were evaluated using two-way ANOVA with post hoc Tukey’s multiple comparisons test. Survival outcomes were assessed by Kaplan-Meier analysis. (*p < 0.05, **p < 0.01, ****p < 0.0001). HLJD = Huang Lian Jie Du Decoction, ICIs = anti-PD-1 + anti-CTLA-4

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us